#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic kidney disease Choroid melanoma Toxic epidermal necrolysis Malformation venous Angelman's syndrome Hyperchylomicronaemia Pulmonary fibrosis Hypereosinophilic syndrome Short stature Barth syndrome Lymphangioma Rheumatoid arthritis Hypoparathyroidism Cholangiocarcinoma Peritoneal neoplasm More trials…

    Learn about Rare Diseases

    Hereditary angioedema – Diagnostics Leukoencephalopathy – Treatment Testicular leiomyosarcoma – Treatment Haemolytic uraemic syndrome – Life with Disease Systemic sclerosis pulmonary – Treatment Sarcoma – Treatment Paraneoplastic neurological syndrome – Treatment Brain stem glioma – Life with Disease Systemic sclerosis pulmonary – Life with Disease X-linked lymphoproliferative syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Paracetamol Ph. Eur. Dexamethasone Sodium Phosphate Calcium Minoxidil Cetrorelix Ferric Carboxymaltose Bisacodyl Istaroxime Transpocart19 Ergocalciferol Denosumab Dazucorilant Montelukast Sodium Paroxetine Glycopyrronium Bromide Ds-2325A Gliclazide Flutemetamol (18F) GVV858 Interferon Gamma More therapies…

    Learn about Your Condition

    Psychological trauma Femur fracture Optic glioma Microscopic polyangiitis Cognitive disorder Sinusitis bacterial Hypogonadism male Solitary fibrous tumour B-cell lymphoma Intermittent claudication Nasopharyngeal cancer Primary myelofibrosis Diabetes insipidus Coeliac disease Adenocarcinoma of colon More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hepatocellular carcinoma

  • Study on Fecal Microbiota Transfer with Vancomycin, Atezolizumab, and Bevacizumab for Patients with Advanced Liver Cancer

    Recruiting

    2 1 1
    Investigated Diseases:
    • Hepatocellular carcinoma
    Investigated Drugs:
    • Intestifix
    • Vancomycin Hydrochloride
    • Bevacizumab
    Germany

  • Study of E7386 and Lenvatinib for Patients with Liver, Colon, Endometrial, or Other Solid Tumors

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Endometrial cancer
    • Hepatocellular carcinoma
    • Colorectal cancer
    Investigated Drugs:
    • (6S,9As)-8-((6-(3-(4-Ethyl-1-Piperazinyl)-1-Azetidinyl)-2-Pyridinyl)Methyl)-6-((2-Fluoro-4-Hydroxyphenyl)Methyl)Hexahydro-4,7-Dioxo-N-(Phenylmethyl)-2-(2-Propen-1-Yl)-2H-Pyrazino(2,1-C)(1,2,4)Triazine-1(6H)-Carboxamide
    • Doxorubicin Hydrochloride
    • Lenvatinib
    Denmark France Italy Spain

  • Study on the Effectiveness of Durvalumab and Bevacizumab for Patients with Liver Cancer at High Risk of Recurrence After Surgery or Ablation

    Recruiting

    3 1 1
    Investigated Diseases:
    • Hepatocellular carcinoma
    Investigated Drugs:
    • Dextrose Bp
    • Bevacizumab
    • Durvalumab
    Austria France Germany Italy Poland

  • Study on the Effectiveness and Safety of TPST-1120 and Drug Combination for Patients with Advanced Liver Cancer

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Hepatocellular carcinoma
    Investigated Drugs:
    • 3-Fluoro-5-{[(2Ar,4S)-1,1,2,2,4-Pentafluoro-2A-Hydroxy-2,2A,3,4-Tetrahydro-1H-Cyclopenta[Cd]Inden-5-Yl]Oxy}Benzonitrile
    • Adg126
    • Human Igg4 Monoclonal Antibody Against Lilrb2
    France

  • Study on Atezolizumab, Bevacizumab, and EXL01 for Patients with Liver Cancer Not Responding to First-Line Immunotherapy

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Exl01
    • Bevacizumab
    • Tremelimumab
    France

  • Study on UCPVax, Atezolizumab, and Bevacizumab for Patients with Unresectable Liver Cancer

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Ucp4
    • Bevacizumab
    • Atezolizumab
    France
Previous Page
1 … 3 4 5 6 7 … 15
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!